563 results on '"Panayi, G. S."'
Search Results
2. Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis
3. Corticotropin releasing hormone (CRH) promoter polymorphisms in various ethnic groups of patients with rheumatoid arthritis
4. Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?
5. Improved glycaemic control with disease remission in rheumatoid arthritis and hypoglycaemic effect of sulphasalazine
6. Irish society for rheumatology: Proceedings of annual general meeting held in Beaumont Hospital on Friday 22nd October, 1993
7. Irish association of rheumatology & rehabilitation: Proceedings of annual general meeting, Friday 6th November 1992 at St. Vincent’s Hospital, Elm Park, Dublin
8. Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkinʼs lymphoma
9. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?
10. Introduction
11. Irish association of rheumatology&rehabilitation: Proceedings of Annual General Meeting held November 1991
12. Proliferation of peripheral blood mononuclear cells from rheumatoid arthritis patients to mycobacterial antigens
13. Anti-BiP antibody levels in juvenile idiopathic arthritis (JIA)
14. Antibody response to the human stress protein BiP in rheumatoid arthritis
15. Differences in the postgraduate medical training system in rheumatology between the United Kingdom and Japan
16. BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals
17. Third International Symposium for health professionals in rheumatology: Enschede 6–9 June 1990
18. Therapeutic Benefit of Blocking Interleukin-6 Activity With an Anti–Interleukin-6 Receptor Monoclonal Antibody in Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial
19. Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial
20. BLOCKING INTERLEUKING-6 (IL-6) BY AN ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) MONOCLONAL ANTIBODY IN RHEUMATOID ARTHRITIS (RA)
21. The role of TNF-α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera
22. Stromal Cell–Derived Factor 1 (CXCL12) Induces Monocyte Migration Into Human Synovium Transplanted Onto SCID Mice
23. Control of Rheumatoid Arthritis by Oral Tolerance
24. TNFα does not increase lymphocyte migration to fetal gut transplanted into severe combined immunodeficient (SCID) mice
25. Tumour necrosis factor-alpha (TNF-α) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice
26. CD8+,CD57+ T CELLS FROM HEALTHY ELDERLY SUBJECTS SUPPRESS NEUTROPHIL DEVELOPMENT IN VITRO: Implications for the Neutropenia of Felty’s and Large Granular Lymphocyte Syndromes
27. FIBROBLAST-LIKE SYNOVIOCYTES (FLS) INDUCE ANERGY IN T CELLS IN THE ABSENCE OF CD80 EXPRESSION
28. EFFECTS OF INFLAMMATION AND TREATMENT ON BONE TURNOVER AND BONE MASS IN POLYMYALGIA RHEUMATICA
29. T CELL HYPOTHESIS IN RHEUMATOID ARTHRITIS (RA) TESTED BY HUMANISED NON-DEPLETING ANTI-CD4 MONOCLONAL ANTIBODY (mAb) TREATMENT I: SUPPRESSION OF DISEASE ACTIVITY AND ACUTE PHASE RESPONSE.: OGg379
30. T CELL HYPOTHESIS IN RHEUMATOID ARTHRITIS (RA) TESTED BY HUMANISED NON-DEPLETING ANTI-CD4 MONOCLONAL ANTIBODY (mAb) TREATMENT II: CLINICAL ACTIVITY IS RELATED TO PHARMACODYNAMIC EFFECTS.: OGg378
31. LIPOCORTIN DOES NOT MEDIATE THE INHIBITION OF ADHESION MOLECULE EXPRESSION INDUCED BY GLUCOCORTICOIDS.: T200
32. Reply: Severity of rheumatoid arthritis in Greek versus English patients: comment on the article by Drosos et al
33. Hematologic and Cytofluorographic Analysis of Patients with Felty's Syndrome: A Hypothesis that a Discrete Event Leads to Large Granular Lymphocyte Expansions in this Condition
34. Authors reply: Effect of gold treatment on cytokine expression in synovium
35. Human chimaeric antibody response in rheumatoid arthritis patients after treatment with a chimaeric anti-CD4 monoclonal antibody CM-T412
36. Treatment of rheumatoid arthritis with engineered human antibody to tumour necrosis factor alpha: CDP571
37. Autoantigens in rheumatoid arthritis
38. Genetic Basis Of Rheumatoid Disease: Hla Antigens, Disease Manifestations, And Toxic Reactions To Drugs
39. Circadian Variation In Disease Activity In Rheumatoid Arthritis
40. Pulse Treatment With Methylprednisolone In Rheumatoid Arthritis
41. Unified Concept Of Cell-Mediated Immune Reactions
42. Chairman’s Summary
43. Natural killer cell activity in inflammatory joint disease
44. Failure of sodium aurothiomalate and triethyl phosphine gold to cause renal tubular injury in rheumatoid arthritis: implications for the aetiology of gold-related nephropathy
45. Second-line drug treatment in rheumatoid arthritis associated with depressed autologous mixed lymphocyte reaction
46. The effect of clotrimazole on human lymphocyte responsiveness to plant mitogens
47. Delayed cutaneous hypersensitivity in rheumatoid arthritis: The influence of nutrition and drug therapy
48. Eular workshop on Rheumatology Research: Noordwijkerhout February 1982
49. IX Eular Workshop for Rheumatology Research: Molecular biology of autoantigens, autoantibodies and immunopeptides. Vienna, Austria, March 9–12, 1989
50. Gold-induced thrombocytopenia: Detection of anti-platelet antibody
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.